4 ms·
You can't just reduce the patent period without reducing the regulatory process that is required to get stuff approved. It would not work otherwise.
by ekianjo 8y ago
You can't just reduce the patent period without reducing the regulatory process that is required to get stuff approved. It would not work otherwise.
- lotsofpulp 8y agoI hope we're not on the path to reducing rigorous testing and vetting of medicines in exchange for cheaper prices. Medical science is extremely hard, and verifying cause and effect in a system as complex as the human body takes significant resources. People want cheap, people want safe, people want well qualified individuals pursuing these advances. What people don't want is higher taxes to enable government funding for this research, and would rather have private investors pick up the tab. And then they scoff at high medicine prices. I'm sure there's some corruption and paper pushing waste going on, but fixing that is not going to remove the need for costly triple blind studies that span years, only to result in failure the vast majority of the time. That's the cost of good science, and if society wants the fruits, they need to pay for it.
- prolikewhoa 8y agoIt's so weird to me that people won't pay taxes for the government research, but then complain when the drugs are out of their price range because the corporation needs extensive profits to make up their costs so the consumer likely end up paying more than they'd pay in taxes for the research and public benefit.
- boyband6666 8y agoThis is exactly correct. Also there is a good incentive structure in there - a well designed clinical trial program will move between phases, collect all data possible to support an application, and have all the relevant data to get a timely approval. The better you do on evidence collection, the sooner you are on the market, and more you have to work with
- bluGill 8y agoNote that even if government pays, the costs still exist. Maybe the government can decide researchers are worth less money, but or some such - if they are willing to drive researches in it for money out (everybody is in it for money at some point, as you need to eat and you like other luxuries money can buy: the only question is when it is worth leaving).
- ekianjo 8y ago> I hope we're not on the path to reducing rigorous testing and vetting of medicines in exchange for cheaper prices The FDA has extremely long review cycles. To say that this could be not be improved, while still keeping the same standards (or even better ones) is unlikely. Anyway, I don't think it's likely that we will see anyone touching the patent system anytime soon, so it's merely a thought exercise at this stage.
- mattkrause 8y agoThe FDA has a mechanism (market exclusivity) that is intended to compensate for regulatory delays.
- hammock 8y agoThe two are interlinked and I believe it would happen naturally in large part. Long patents buttress profits for drug makers, allowing for increased regulatory capture and increased FDA power. The opposite is also true.